Nr565 week 6 exam Study guides, Class notes & Summaries

FINAL EXAM NR565/ NR 565 ADVANCED PHARMACOLOGY TEST Psyllium - CORRECT ANSWER-Bulk-forming laxative that softens fecal mass and increases bulk Fecal impaction - CORRECT ANSWER-Condition when psyllium doesn't produce a bowel movement IBS - CORRECT ANSWER-Diagnosis and treatment aided by keeping a diary Tdap vaccine recipients - CORRECT ANSWER-Immunocompromised, cancer, HIV, high-dose glucocorticoid, pregnancy Contraindication for DTaP or Tdap vaccine - CORRECT ANSWER-History of a...

Types of DM 1. Type 1- severe insulin deficiency resulting in reduction or absence of functioning beta cells in the pancreatic islets of Langerhans. This leads to hyperglycemia due to altered metabolism of lipids, carbs, and proteins. Initial s/s of hyperglycemia. Subjective findings- polyuria, polydipsia, nocturnal enuresis and polyphagia with paradoxical weight loss, visual changes and fatigue. Objective-dehydration(poor skin turgor and dry mucous), wt loss despite normal/increase appetite, r...

NR548 Psychiatric Assessment for Psychiatric-Mental Health Nurse Practitioner — November 2023 Faculty Information Name: Dixie Zimmerman Email: Phone Number: Office Hours: By email/appointment only Hello, I look forward to working with you all. I am a Kentucky based Psychiatric Nurse Practitioner who has worked with clients across the lifespan. I have always been passionate about psychiatric nursing and hope to be a help to you on your journey. Please email me with any questions ...

NR565 midterm, week 4 Exam Questions and Answers what makes clopidogrel unique among other P2Y12 inhibitors? - Answer-relies on cytochrome P450 enzyme to convert into active metabolite (CYP2C19) thus requiring this gene to be present to be an effective drug in clot formation Alternatives to clopidogrel - Answer-Brilinta (ticagrelor) or Effient (Prasugrel) because they are not dependent on CYP2C19 genotype Name the 4 medications that REQUIRE pharmacogenetic testing - Answer-Cetuximab, tra...

NR565- PHARMACOLOGY EXAM PRACTICE preclinical research - CORRECT ANSWER-Research of drug potential, animal testing, preparation for human testing Phase I - CORRECT ANSWER-Initial clinical safety studies in humans. May be as few as 10 subjects, often healthy volunteers Phase II - CORRECT ANSWER-The study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety Phase III - CORRECT ANSWER-The study drug or treatment i...

NR565 Week 5: Endocrine System Case Study – Helen Smith, Alfonso Giuliani, John Jones Question 1 I understand the value of doing my own work and learning this skill to support my future independent practice as a nurse practitioner. I understand that while there may be opportunities beyond my faculty’s control to collaborate or share answers with peers, that it would not benefit my own personal and professional growth to do so. I agree to do my own work and take personal responsibility for my...

NR565 Week 5: Endocrine System Case Study – Helen Smith, Alfonso Giuliani, John Jones Question 1 I understand the value of doing my own work and learning this skill to support my future independent practice as a nurse practitioner. I understand that while there may be opportunities beyond my faculty’s control to collaborate or share answers with peers, that it would not benefit my own personal and professional growth to do so. I agree to do my own work and take personal responsibility f...

NR565 Week 4 Study Guide Week 4 is the midterm (no quiz) and includes all material from Weeks 1-4; Be sure to also review the Weeks 1, 2 & 3 study guides to prepare for the exam Many questions will are written to assess your clinical application of the material from the textbook, in real-world scenarios Chapter 15: Drugs Affecting the Central Nervous System Anorexiants: Precautions and contraindications Examples; phentermine, benzphetamine, diethylproprion, phendiametrazine and lorcase...

NR565- PHARMACOLOGY EXAM PRACTICE preclinical research - CORRECT ANSWER-Research of drug potential, animal testing, preparation for human testing Phase I - CORRECT ANSWER-Initial clinical safety studies in humans. May be as few as 10 subjects, often healthy volunteers Phase II - CORRECT ANSWER-The study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety Phase III - CORRECT ANSWER-The study drug or treatment i...

NR565 Week 5: Endocrine System Case Study – Helen Smith, Alfonso Giuliani, John Jones Question 1 I understand the value of doing my own work and learning this skill to support my future independent practice as a nurse practitioner. I understand that while there may be opportunities beyond my faculty’s control to collaborate or share answers with peers, that it would not benefit my own personal and professional growth to do so. I agree to do my own work and take personal responsibility for my...